Latest News and Press Releases

NEW YORK, Jan. 23, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Instadose Pharma Corp. f/k/a Mikrocoze, Inc. (“Instadose”, “Mikrocoze”, or the...

NEW YORK, Jan. 23, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Desktop Metals, Inc. (“Desktop Metal” or the “Company”) (NYSE: DM) and certain...

NEW YORK, Jan. 23, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Volkswagen AG (“Volkswagen” or the “Company”) (OTCMKTS: VWAGY) and certain of...

NEW YORK, Jan. 23, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against NRx Pharmaceuticals, Inc. (“NRx” or the “Company”) (NASDAQ: NRXP; NRXPW) and...

NEW YORK, Jan. 23, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Berkeley Lights, Inc. (“Berkeley Lights” or the “Company”) (NASDAQ: BLI).   Such investors...

NEW YORK, Jan. 23, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Cloopen Group Holding Limited (“Cloopen” or the “Company”) (NYSE: RAAS). Such investors...

NEW YORK, Jan. 23, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Exicure, Inc. (“Exicure” or the “Company”) (NASDAQ: XCUR).   Such investors are advised to...

NEW YORK, Jan. 23, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Redwire Corporation f/k/a Genesis Park Acquisition Corp. (“Redwire” or the “Company”)...

NEW YORK, Jan. 23, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of KE Holdings Inc. (“KE Holdings” or the “Company”) (NYSE: BEKE).   Such investors are...

NEW YORK, Jan. 23, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Talis Biomedical Corporation (“Talis” or the “Company”) (NASDAQ: TLIS).   Such investors...